Cargando…

Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists

The increasing prevalence of obesity and type 2 diabetes (T2DM) is provoking an important socioeconomic burden mainly in the form of cardiovascular disease (CVD). One successful strategy is the so-called metabolic surgery whose beneficial effects are beyond dietary restrictions and weight loss. One...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiménez-Martí, Elena, Hurtado-Genovés, Gema, Aguilar-Ballester, María, Martínez-Hervás, Sergio, González-Navarro, Herminia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503433/ https://www.ncbi.nlm.nih.gov/pubmed/36145148 http://dx.doi.org/10.3390/nu14183775

Ejemplares similares

Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia
por: Aguilar-Ballester, María, et al.
Publicado: (2021)

Impact of Cholesterol Metabolism in Immune Cell Function and Atherosclerosis
por: Aguilar-Ballester, María, et al.
Publicado: (2020)

Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance
por: Taberner-Cortés, Alida, et al.
Publicado: (2020)

Dissecting Abdominal Aortic Aneurysm Is Aggravated by Genetic Inactivation of LIGHT (TNFSF14)
por: Herrero-Cervera, Andrea, et al.
Publicado: (2021)

Sex hormones, aging and cardiometabolic syndrome
por: Faulkner, Jessica L., et al.
Publicado: (2019)

Scheduled simple production method of pseudopregnant female mice for embryo transfer using the luteinizing hormone-releasing hormone agonist
por: Sari, Gema Puspa, et al.
Publicado: (2022)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

Editorial: Steroid hormone receptors in cardiometabolic disease
por: Goodwin, Julie, et al.
Publicado: (2023)

The Importance of Natriuretic Peptides in Cardiometabolic Diseases
por: Vinnakota, Shravya, et al.
Publicado: (2020)

Structural Motif Descriptors as a Way To Elucidate the Agonistic or Antagonistic Activity of Growth Hormone–Releasing Hormone Peptide Analogues
por: Jeanne Dit Fouque, Kevin, et al.
Publicado: (2018)

The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
por: Cordido, Fernando, et al.
Publicado: (2010)

Unique peptidic agonists of a juvenile hormone receptor with species-specific effects on insect development and reproduction
por: Tumova, Sarka, et al.
Publicado: (2022)

Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases
por: Hölscher, Christian
Publicado: (2022)

Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1
por: Gasser, Adeline, et al.
Publicado: (2015)

Cardiometabolic Risks During Anabolic Hormone Supplementation in Older Men
por: He, J., et al.
Publicado: (2013)

Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
por: Salvatore, Teresa, et al.
Publicado: (2019)

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
por: Michałowska, Joanna, et al.
Publicado: (2021)

A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
por: Hoseini, Fatemeh Sadat, et al.
Publicado: (2014)

Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue
por: Yang, Fan, et al.
Publicado: (2022)

Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty
por: Wu, Vickie, et al.
Publicado: (2021)

Pedigree- and SNP-Associated Genetics and Recent Environment are the Major Contributors to Anthropometric and Cardiometabolic Trait Variation
por: Xia, Charley, et al.
Publicado: (2016)

Food Insecurity and Cardiometabolic Conditions: a Review of Recent Research
por: Te Vazquez, Jennifer, et al.
Publicado: (2021)

Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases
por: Hernandez, Rebecca, et al.
Publicado: (2021)

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
por: Fisman, Enrique Z., et al.
Publicado: (2021)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

Theory of partial agonist activity of steroid hormones
por: Chow, Carson C., et al.
Publicado: (2015)

Unsaturated Oral Fat Load Test Improves Glycemia, Insulinemia and Oxidative Stress Status in Nondiabetic Subjects with Abdominal Obesity
por: Martinez-Hervas, Sergio, et al.
Publicado: (2016)

Anti-Müllerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females
por: Anderson, Emma L., et al.
Publicado: (2013)

Gut Microbiota and Sex Hormones: Crosstalking Players in Cardiometabolic and Cardiovascular Disease
por: Maffei, Silvia, et al.
Publicado: (2022)

Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
por: Spicer, Darcy V, et al.
Publicado: (2000)

Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor
por: Duan, Jia, et al.
Publicado: (2023)

A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1
por: Hossain, Mohammed Akhter, et al.
Publicado: (2016)

Chronotype and Cardiometabolic Parameters in Patients with Bipolar Disorder: Preliminary Findings
por: Aguglia, Andrea, et al.
Publicado: (2023)

Effects of intravenous administration of neurokinin receptor subtype-selective agonists on gonadotropin-releasing hormone pulse generator activity and luteinizing hormone secretion in goats
por: YAMAMURA, Takashi, et al.
Publicado: (2014)

Correction: Pedigree- and SNP-Associated Genetics and Recent Environment are the Major Contributors to Anthropometric and Cardiometabolic Trait Variation
por: Xia, Charley, et al.
Publicado: (2017)

Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors
por: Culhane, Kelly J., et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
por: Keane, Fergus, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
por: Shiasi Arani, Kobra, et al.
Publicado: (2015)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

Dual gut hormone receptor agonists for diabetes and obesity
por: Bass, Joseph, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ik58qi7c6dttgfg2jihio171v2